Literature DB >> 33938314

Moral distress in medicine: An ethical analysis.

Alexandra Kherbache1, Evelyne Mertens1, Yvonne Denier1.   

Abstract

Moral distress is a negative emotional response that occurs when physicians know the morally correct action but are prevented from taking it because of internal or external constraints. Moral distress undermines a physician's ethical integrity, leading to anger, poor job satisfaction, reduced quality of care and burnout. Scarce literature exists on the ethical aspects of moral distress in medicine. We conducted an ethical analysis of moral distress as experienced by physicians and analysed it from the literature using two predominant ethical theories: principlism and care ethics. Finally, we consider the emergence of moral distress in medicine during the COVID-19 pandemic.

Entities:  

Keywords:  COVID-19; care ethics; health care; medicine; moral distress; principlism

Mesh:

Year:  2021        PMID: 33938314     DOI: 10.1177/13591053211014586

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  3 in total

1.  "There Was a Sense That Our Load Had Been Lightened": Evaluating Outcomes of Virtual Ethics Rounds for Veterinary Team Members.

Authors:  Anne Quain; Siobhan Mullan; Michael P Ward
Journal:  Front Vet Sci       Date:  2022-07-18

2.  Moral distress among clinicians working in US safety net practices during the COVID-19 pandemic: a mixed methods study.

Authors:  Donald E Pathman; Jeffrey Sonis; Thomas E Rauner; Kristina Alton; Anna S Headlee; Jerry N Harrison
Journal:  BMJ Open       Date:  2022-08-25       Impact factor: 3.006

3.  Companions in the Abyss: A Feasibility and Acceptability Study of an Online Therapy Group for Healthcare Providers Working During the COVID-19 Pandemic.

Authors:  Lorraine Smith-MacDonald; Jaimie Lusk; Dayna Lee-Baggley; Katherine Bright; Alexa Laidlaw; Melissa Voth; Shaylee Spencer; Emily Cruikshank; Ashley Pike; Chelsea Jones; Suzette Bremault-Phillips
Journal:  Front Psychiatry       Date:  2022-01-14       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.